Korro Bio (KRRO) Minority Interest (2018 - 2019)
Korro Bio (KRRO) posted Minority Interest of $3.8 million for Q3 2019, little changed on a QoQ basis from $3.8 million in Q4 2018.
Korro Bio (KRRO) Minority Interest (2018 - 2019) Analysis & Trends
Korro Bio's Minority Interest history runs 2 years deep, the most recent figure standing at $3.8 million for Q3 2019.
- Quarterly Minority Interest changed N/A year-over-year to $3.8 million in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $3.8 million (changed N/A YoY) and the FY2018 annual result came in at $3.8 million, changed N/A from the prior year.
- Minority Interest was $3.8 million for Q3 2019 at Korro Bio, roughly flat from $3.8 million in the prior quarter.
- Across five years, Minority Interest topped out at $3.8 million in Q4 2018 and bottomed at $3.8 million in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Korro Bio | 123.70 Mn | 9.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 3.77 Mn |
| Dec 31, 2018 | 3.77 Mn |